Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Chandra Bhagat Pharma IPO is a fixed price issue of ₹10.20 crores. The issue is entirely a fresh issue of 0.20 crore shares of ₹10.20 crore.
Chandra Bhagat Pharma IPO bidding started from Jan 31, 2020 and ended on Feb 6, 2020. The allotment for Chandra Bhagat Pharma IPO was finalized on Feb 11, 2020. The shares got listed on BSE SME on Feb 14, 2020.
Chandra Bhagat Pharma IPO price is ₹51.00 per share . The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹1,02,000 (2000 shares). The minimum lot size investment for HNI is 2 lots (4,000 shares), amounting to ₹2,04,000.
Beeline Broking Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue. The market maker of the company is Beeline Broking Ltd..
Refer to Chandra Bhagat Pharma IPO RHP for detailed Information.
| IPO Date | January 31, 2020 to February 6, 2020 |
| Listing Date | February 14, 2020 |
| Face Value | ₹10 per share |
| Issue Price Band | |
| Issue Price Final | ₹51 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 20,00,000 shares (aggregating up to ₹10.20 Cr) |
| Reserved for Market Maker | 1,00,000 shares Beeline Broking Ltd. (aggregating up to ₹0.5100 Cr) |
| Net Offered to Public | 19,00,000 shares (aggregating up to ₹9.69 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 55,45,056 shares |
| Share Holding Post Issue | 75,45,056 shares |
CBC Pharma IPO offers total 20,00,000 shares. Out of which 9,50,000 (47.50%) allocated to NII, 9,50,000 (47.50%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 1,00,000 (5.00%) |
| NII (HNI) Shares Offered | 9,50,000 (47.50%) |
| Retail Shares Offered | 9,50,000 (47.50%) |
| Total Shares Offered | 20,00,000 (100.00%) |
Chandra Bhagat Pharma IPO opens on January 31, 2020, and closes on February 6, 2020.
| IPO Open Date | Fri, Jan 31, 2020 |
| IPO Close Date | Thu, Feb 6, 2020 |
| Tentative Allotment | Tue, Feb 11, 2020 |
| Initiation of Refunds | Thu, Feb 13, 2020 |
| Credit of Shares to Demat | Thu, Feb 13, 2020 |
| Tentative Listing Date | Fri, Feb 14, 2020 |
| Cut-off time for UPI mandate confirmation | 5 PM on Thu, Feb 6, 2020 |
Investors can bid for a minimum of 2,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹1,02,000 |
| Retail (Max) | 1 | 2,000 | ₹1,02,000 |
| HNI (Min) | 2 | 4,000 | ₹2,04,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2003, Chandra Bhagat Pharma Limited is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. They provide pharmaceuticals and special chemical products in the Indian and international market.
The company has own sales force and distribution network to work under the brand name and supply products to the Health care center and Hospital. Chandra Bhagat Pharma also deals in import, supply and indenting in Active Pharmaceuticals Ingredients (API) and the intermediate.
The company has FDA approval to get formulations manufactured from a contract manufacturer. It has a presence for formulations in some therapeutic categories such as Anesthesia, Cardiovascular, Anti-cancer (Oncology), Pediatrics, Nephrology, Antiviral, Anti-fungal, and Neurology. The warehouses/ storage houses of the company are on lease agreements at Bhiwandi- Thane, Maharashtra.
Chandra Bhagat Pharma also exports Pharmaceutical Formulations to other countries like DR Congo, Bolivia and Philippines.
Competitive Strengths
1. Customer centric and order driven business model
2. Relationships with MNCs
3. Wide product portfolio including API and pharmaceuticals
4. Contract manufacturing facility
5. Presence in India and international market
| Particulars | For the year/period ended (Rs in Lakhs) | ||||
|---|---|---|---|---|---|
| 30-July-19 | 31-Mar-19 | 31-Mar-18 | 31-Mar-17 | ||
| Total Assets | 8,594.26 | 8,285.52 | 5,805.76 | 5,589.60 | |
| Total Revenue | 3,344.50 | 10,671.83 | 9,773.41 | 9,028.11 | |
| Profit After Tax | 24.88 | 62.59 | 103.38 | 66.03 | |
The market capitalization of Chandra Bhagat Pharma IPO is ₹38.48 Cr.
| Pre IPO | Post IPO | |
|---|---|---|
| P/E (x) | 51 |
The Company Chandra Bhagat Pharma IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | To Meet Incremental Working Capital Requirements | 7.00 |
| 2 | Setting up Distribution and Warehousing Centre’s | 1.50 |
| 3 | General Corporate Purpose | 0.95 |
| 4 | To meet Public Issue Expenses | 0.75 |
[Dilip Davda] CBPL has shown inconsistency in bottom lines despite growing top lines. With the vaccine product launch plans up the sleeve, it is poised for bright prospects as claimed by the management. However, all these positive factors are discounted in the asking price. Hence only cash surplus, risk savvy investors may consider investment for long term at their own risk. Read detail review...
| Listing Date | February 14, 2020 |
| BSE Script Code | 542934 |
| NSE Symbol | |
| ISIN | INE07QQ01016 |
| Final Issue Price | ₹51 per share |
| BSE Listing Group | MT |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹51.00 |
| Open | ₹51.70 |
| Low | ₹51.00 |
| High | ₹52.10 |
| Last Trade | ₹51.75 |
Chandra Bhagat Pharma Ltd.
323-F Bhagat Bhuvan,
Dr. Ambedkar Road,
Matunga (East),
Mumbai, Maharashtra, 400019
Phone: +91 22 2414 6154
Email: compliance@cbcpharma.net
Website: http://cbcpharma.com/
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: cbpl.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Chandra Bhagat Pharma IPO is a SME IPO of 20,00,000 equity shares of the face value of ₹10 aggregating up to ₹10.20 Crores. The issue is priced at ₹51 per share. The minimum order quantity is 2000.
The IPO opens on January 31, 2020, and closes on February 6, 2020.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Chandra Bhagat Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Chandra Bhagat Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Chandra Bhagat Pharma IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Chandra Bhagat Pharma IPO opens on January 31, 2020 and closes on February 6, 2020.
Chandra Bhagat Pharma IPO lot size is 2000, and the minimum amount required for application is ₹1,02,000.
You can apply in Chandra Bhagat Pharma IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Chandra Bhagat Pharma IPO will be done on Tuesday, February 11, 2020, and the allotted shares will be credited to your demat account by Thursday, February 13, 2020. Check the Chandra Bhagat Pharma IPO allotment status.
The Chandra Bhagat Pharma IPO listing date is on Friday, February 14, 2020.
Useful Articles
RHP